Cancer megafunds with in silico and in vitro validation: accelerating cancer drug discovery via financial engineering without financial crisis

Advances in financial engineering are radically reshaping the biomedical marketplace. For instance, new methods of pooling diversified drug development programs by placing them in a special purpose vehicle (SPV) have been proposed to create a securitized cancer megafund allowing for debt and equity...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xianjin, Debonneuil, Edouard, Zhavoronkov, Alex, Mishra, Bud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295380/
https://www.ncbi.nlm.nih.gov/pubmed/27275544
http://dx.doi.org/10.18632/oncotarget.9808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295380/
https://www.ncbi.nlm.nih.gov/pubmed/27275544
http://dx.doi.org/10.18632/oncotarget.9808

Ejemplares similares